Free Press Bulletin: Top 5 news updates of June 3, 2021; watch video

04:45 PM Jun 03, 2021 | FPJ Web Desk

Here are the top 5 news updates of June 3, 2021:

1. Mumbai likely to get 87,000 Covishield doses on June 4: Mayor Kishori Pednekar


Mumbai is expected to get a supply of 87,000 doses of Covishield vaccine against COVID-19 on Friday and the inoculation drive would resume in the city the next day, Mayor Kishori Pednekar said on Thursday.


Due to the unavailability of enough vaccine doses, the COVID-19 vaccination drive in Mumbai was suspended on Thursday at centres run by the city civic body and the Maharashtra government, the Brihanmumbai Municipal Corporation (BMC) earlier said.

Of the total 342 active COVID-19 vaccination centres in Mumbai, 243 are managed by the BMC and 20 by the state government.

Also Read: Viral: Mumbai Mayor slammed for her Twitter reply to citizen asking about vaccine contract

2. Centre signs deal with Biological-E for 30 crore COVID-19 vaccine doses

The Union Health Ministry has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to reserve 30 crore COVID-19 vaccine doses for which it will be making an advance payment of Rs 1500 crore.

This is the second made-in-India vaccine after Bharat Biotech's COVAXIN. As per a health ministry statement on Thursday, these vaccine doses will be manufactured and stockpiled by Biological-E from August to December this year.

The COVID-19 vaccine of Biological-E is currently undergoing phase-3 clinical trial after showing promising results in phase 1 and 2 trials. The vaccine being developed by Biological-E is a RBD protein sub-unit vaccine and is likely to be available in the next few months.

The proposal of Biological-E was examined and recommended for approval after due diligence by the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC), the statement said.

Also Read: Mumbai: Haffkine Bio-Pharma gets approval for Covaxin production; in talks with Bharat Biotech to initiate process

3. Centre-WhatsApp clash continues: New affidavit with Delhi HC says company obtaining 'trick consent' from users

The Centre's rift with WhatsApp appears to be continuing, with the administration informing the Delhi High Court on Thursday that the Facebook-owned organisation was indulging in anti-user practices. In a fresh affidavit, the government said that WhatsApp was obtaining "trick consent" from users for its updated privacy policy.

The Centre submitted before the Delhi HC that WhatsApp had unleashed its digital prowess to existing users and would force them to accept updated 2021 privacy policy, to transfer existing user base committed to updated privacy policy before Personal Data Protection (PDP) Bill becomes law.

Also Read: WhatsApp says won't limit functionality; to continue to send reminders for users to accept privacy policy

4. Gautam Gambhir’s foundation guilty of illegally stocking, distributing Fabiflu drug to COVID-19 patients: Drug Controller tells Delhi HC

The Gautam Gambhir Foundation has been found guilty of unauthorisedly stocking, procuring and distributing Fabiflu medicine to COVID-19 patients, the Delhi High Court was informed by the Delhi government's drug controller on Thursday.

The drug controller submitted that action will be taken without delay against the foundation, drug dealers as also in other such cases which would be brought to its notice.

MLA Praveen Kumar has also been found guilty for similar offences under the Drugs and Cosmetics Act, the court was informed.

The court asked the drug controller to file status reports on further progress in these cases within six weeks and listed the matter for hearing on July 29.

Also Read: 'Have provided all details': BJP MP Gautam Gambhir after Delhi Police asks him to explain distribution of Fabiflu from his office

5. Bulls rebound after two lackluster sessions as Sensex, Nifty close at record high on renewed buying

Tracking positive global cues, Indian equity market opened on a positive note while positive GDP data and declining COVID-19 cases also supported the sentiments. HDFC twins, Kotak bank, Titan and L&T were the top contributors to index gains. Index heavyweight Nifty Bank surged nearly 0.8 percent ahead of RBI’s monetary policy. All the sectoral indices ended in the green zone except Nifty Pharma while Nifty Realty was the top performer in today’s session.

Market participants will keep a close eye on US payroll data and RBI’s monetary policy which is scheduled tomorrow.

While the Nifty is moving towards 16,000, it has set a new record closing high. Titan, ONGC and L&T helped bring the Nifty to end at higher levels.

(To view our epaper please Read Now. For all the latest News, Mumbai, Entertainment, Cricket, Business and Featured News updates, visit Free Press Journal. Also, follow us on Twitter and Instagram and do like our Facebook page for continuous updates on the go)